2025 Publications

  1. Halloran PF, Madill-Thomsen KS, Bohmig G, Bromberg J, Budde K, Barner M, et al. Subthreshold rejection activity in many kidney transplants currently classified as having no rejection. Am J Transplant. 2025;25(1):72-87.
  2. Halloran PF, Madill-Thomsen KS. Donor-derived Cell-free DNA: A Step Forward in the Quest for Transplant Truth. Transplantation 2025;109(6):910-914.
  3. Halloran PF, Chang J, Mackova M, Madill-Thomsen KS, et al. A cross-sectional study of the role of epithelial cell injury in kidney transplant outcomes. JCI Insight 2025;10(10):e188658.
  4. Madill-Thomsen KS, Venner JM, et al. Relating the molecular phenotype of ulcerative colitis to the clinical course. Nature Scientific Reports 2025;15(1):8342.
  5. Madill-Thomsen KS, Hidalgo LG, Demko Z, Gauthier PM, et al. Defining relationships among tests for kidney transplant antibody-mediated rejection. KI Reports 2025; In press. https://doi.org/10.1016/j.ekir.2025.06.017
  6. Hinze C, Pfefferkorn AM, Jahn L, Gauthier PT, Leiz J, Safraz S, et al. Thick ascending limb injury critically impacts kidney allograft survival after T-cell-mediated rejection. Nature Communications. 2025;https://doi.org/10.21203/rs.3.rs-5683198/v1.
  7.  Hidalgo LG, Madill-Thomsen KS, Reeve J, Investigators T-K, Halloran PF. Improving the histologic detection of DSA-negative antibody-mediated rejection in kidney transplants. Am J Transplant. 2025;In press.(https://doi.org/10.1016/j.ajt.2025.08.029).